Literature DB >> 23594419

Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature.

Maarten Arends1, Laura van Dussen, Marieke Biegstraaten, Carla E M Hollak.   

Abstract

Gaucher disease is an autosomal, recessively inherited, lysosomal storage disease, which has been associated with gammopathies and malignancies. This report represents the results of a systematic review of the literature on the prevalence of monoclonal gammopathies and malignancies in Gaucher disease. A PubMed search identified 365 studies, of which 80 reported on concomitant Gaucher disease and malignancies and/or gammopathies (15 cohort/cross sectional studies, and 65 case reports/series). Based on these studies, we conclude that compared to the general population, Gaucher patients have an increased risk of cancer in general [pooled relative risk of 1·70 (95% confidence interval 1·27-2·31)], and multiple myeloma and haematological malignancies in particular (estimated risk between 25·0 and 51·1 and 3·5 and 12·7, respectively). In addition, an increased risk has been reported for hepatocellular carcinoma and renal cell carcinoma. Several factors have been hypothesized to play a role in the pathophysiology. These include: splenectomy, immune dysregulation, endoplasmic reticulum stress, genetic modifiers, altered iron metabolism and insulin resistance.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23594419     DOI: 10.1111/bjh.12335

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  27 in total

1.  Once again, rare diseases provide a spotlight.

Authors:  Tamanna Roshan Lal; Daniel K Borger; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2016-03-05       Impact factor: 4.797

Review 2.  Gaucher disease.

Authors:  Aabha Nagral
Journal:  J Clin Exp Hepatol       Date:  2014-04-21

3.  MGUS, lymphoplasmacytic malignancies, and Gaucher disease: the significance of the clinical association.

Authors:  Neal J Weinreb; Pramod K Mistry; Barry E Rosenbloom; Madhav V Dhodapkar
Journal:  Blood       Date:  2018-04-12       Impact factor: 22.113

4.  Recent advances in the diagnosis and management of Gaucher disease.

Authors:  Sam E Gary; Emory Ryan; Alta M Steward; Ellen Sidransky
Journal:  Expert Rev Endocrinol Metab       Date:  2018-03-12

Review 5.  Gaucher disease: Progress and ongoing challenges.

Authors:  Pramod K Mistry; Grisel Lopez; Raphael Schiffmann; Norman W Barton; Neal J Weinreb; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2016-11-17       Impact factor: 4.797

6.  Glucosylsphingosine but not Saposin C, is the target antigen in Gaucher disease-associated gammopathy.

Authors:  Shiny Nair; Noffar Bar; Mina L Xu; Madhav Dhodapkar; Pramod K Mistry
Journal:  Mol Genet Metab       Date:  2020-02-05       Impact factor: 4.797

Review 7.  Clinical manifestations and management of Gaucher disease.

Authors:  Silvia Linari; Giancarlo Castaman
Journal:  Clin Cases Miner Bone Metab       Date:  2015-10-26

Review 8.  Treatment of lysosomal storage disorders: successes and challenges.

Authors:  Carla E M Hollak; Frits A Wijburg
Journal:  J Inherit Metab Dis       Date:  2014-05-13       Impact factor: 4.982

9.  Severe impairment of regulatory T-cells and Th1-lymphocyte polarization in patients with Gaucher disease.

Authors:  Christos Sotiropoulos; George Theodorou; Constantina Repa; Theodoros Marinakis; Eugenia Verigou; Elena Solomou; Marina Karakantza; Argiris Symeonidis
Journal:  JIMD Rep       Date:  2014-10-12

10.  A double-blind, randomized, placebo-controlled trial studying the effects of Saccharomyces boulardii on the gastrointestinal tolerability, safety, and pharmacokinetics of miglustat.

Authors:  Tatiana Remenova; Olivier Morand; Dominick Amato; Harbajan Chadha-Boreham; Scott Tsurutani; Thorsten Marquardt
Journal:  Orphanet J Rare Dis       Date:  2015-06-19       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.